Meeting Report WHO/Health Canada Consultation on Serological Criteria for Evaluation and Licensing of New Pneumococcal Vaccines
ثبت نشده
چکیده
1. Background information and objectives of the meeting 2. Recommendations for pneumococcal conjugate vaccines in the context of the WHO Biological Standardization Programme 3. The impact of the pneumococcal vaccines worldwide 4. Serological criteria for licensing pneumococcal vaccines 5. Outcomes of the studies conducted by the vaccine manufacturers: experience with
منابع مشابه
How Are New Vaccines Prioritized in Low-Income Countries? A Case Study of Human Papilloma Virus Vaccine and Pneumococcal Conjugate Vaccine in Uganda
Background To date, research on priority-setting for new vaccines has not adequately explored the influence of the global, national and sub-national levels of decision-making or contextual issues such as political pressure and stakeholder influence and power. Using Kapiriri and Martin’s conceptual framework, this paper evaluates priority setting for new vaccines in Uganda at national and sub-na...
متن کاملInfluenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review.
s were reviewed by a single reviewer and, for those studies meeting the eligibility criteria, fulltext articles were obtained. Articles with an unknown eligibility were reviewed with a second clinical epidemiologist and then a group of epidemiologists until consensus was established. Data extraction was carried out by the author. Inclusion Criteria studies comparing clinical efficacy of the i...
متن کاملWHO expert consultation on serotype composition of pneumococcal conjugate vaccines for use in resource-poor developing countries, 26-27 October 2006, Geneva.
Pneumococcal conjugate vaccines induce serotype specific protection, with cross-protection seen between serotypes within certain serogroups. Though most serious pneumococcal infections are caused by relatively small number of serotypes, choices need to be made on the serotypes to be included in the vaccine because of the complexity and cost related to developing and producing vaccines with incr...
متن کاملA review of the changes to the licensing of influenza vaccines in Europe
In 2014, the European Committee for Medicinal Products for Human Use (CHMP) published a draft regulatory guideline for the evaluation of influenza vaccines. Following a public consultation round, the final guidance will be published in the near future. Here, we highlight the main changes in the clinical section in this guideline and discuss the background to these changes and whether the new co...
متن کاملMeeting Report WHO Informal Consultation on Standardization and Evaluation of BCG Vaccines
1 1 Disclaimer: This report contains the collective views of an international group of experts, and does not necessarily represent the decisions or the stated policy of the World Health Organization. 2 4 Abstract The current World Health Organization Requirements for BCG vaccine are in need of revision to address the diversity of sub-strains used for production, potential improvements of qualit...
متن کامل